Superoxide dismutase: a review and a modified protocol for activities measurements in rat livers.

IF 2.5 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Lilian Brites Campos-Shimada, Eduardo Hideo Gilglioni, Rosângela Fernandes Garcia, Elismari Rizato Martins-Maciel, Emy Luiza Ishii-Iwamoto, Clairce Luzia Salgueiro-Pagadigorria
{"title":"Superoxide dismutase: a review and a modified protocol for activities measurements in rat livers.","authors":"Lilian Brites Campos-Shimada,&nbsp;Eduardo Hideo Gilglioni,&nbsp;Rosângela Fernandes Garcia,&nbsp;Elismari Rizato Martins-Maciel,&nbsp;Emy Luiza Ishii-Iwamoto,&nbsp;Clairce Luzia Salgueiro-Pagadigorria","doi":"10.1080/13813455.2018.1520891","DOIUrl":null,"url":null,"abstract":"<p><p>Superoxide dismutase (SOD) enzymes are considered the first line of Defence against reactive oxygen species. Among the intracellular isoforms of SOD, Cu,ZnSOD is widely distributed, and the MnSOD is localised in the mitochondria. The SOD activities have been measured indirectly by inhibiting oxidation reactions. Most techniques assessing the hepatic SOD activity are adaptations of classical methods and differ significantly from each other. This work assessed the hepatic Cu,ZnSOD activity in the supernatants of two different centrifugations, using two isotonic medium and the pyrogallol method. In most studies conducted in rat liver, only the Cu,Zn or total SOD activities were assessed and sometimes the Cu,ZnSOD activity was calculated based on the inhibition by cyanide. But, as demonstrated here, this inhibition is not complete. Besides, the novelty of this work is that we presented a method for the evaluating the Cu,ZnSOD and MnSOD activities separately and from the same liver.</p>","PeriodicalId":8331,"journal":{"name":"Archives of Physiology and Biochemistry","volume":"126 4","pages":"292-299"},"PeriodicalIF":2.5000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/13813455.2018.1520891","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Physiology and Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13813455.2018.1520891","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/10/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 11

Abstract

Superoxide dismutase (SOD) enzymes are considered the first line of Defence against reactive oxygen species. Among the intracellular isoforms of SOD, Cu,ZnSOD is widely distributed, and the MnSOD is localised in the mitochondria. The SOD activities have been measured indirectly by inhibiting oxidation reactions. Most techniques assessing the hepatic SOD activity are adaptations of classical methods and differ significantly from each other. This work assessed the hepatic Cu,ZnSOD activity in the supernatants of two different centrifugations, using two isotonic medium and the pyrogallol method. In most studies conducted in rat liver, only the Cu,Zn or total SOD activities were assessed and sometimes the Cu,ZnSOD activity was calculated based on the inhibition by cyanide. But, as demonstrated here, this inhibition is not complete. Besides, the novelty of this work is that we presented a method for the evaluating the Cu,ZnSOD and MnSOD activities separately and from the same liver.

超氧化物歧化酶:大鼠肝脏活性测定的综述和改进方案。
超氧化物歧化酶(SOD)酶被认为是抵抗活性氧的第一道防线。在细胞内SOD同工型中,Cu、ZnSOD分布广泛,MnSOD定位于线粒体。通过抑制氧化反应间接测定SOD活性。大多数评估肝脏SOD活性的技术都是对经典方法的改编,彼此之间存在显著差异。采用两种等渗介质和邻苯三酚法,对两种不同离心方式下的肝脏上清液中Cu、ZnSOD活性进行了测定。在大多数对大鼠肝脏的研究中,仅评估Cu、Zn或总SOD活性,有时根据氰化物的抑制作用计算Cu、ZnSOD活性。但是,正如这里所展示的,这种抑制并不完全。此外,本工作的新颖之处在于我们提出了一种分别评估Cu、ZnSOD和MnSOD活性的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archives of Physiology and Biochemistry
Archives of Physiology and Biochemistry ENDOCRINOLOGY & METABOLISM-PHYSIOLOGY
CiteScore
6.90
自引率
3.30%
发文量
21
期刊介绍: Archives of Physiology and Biochemistry: The Journal of Metabolic Diseases is an international peer-reviewed journal which has been relaunched to meet the increasing demand for integrated publication on molecular, biochemical and cellular aspects of metabolic diseases, as well as clinical and therapeutic strategies for their treatment. It publishes full-length original articles, rapid papers, reviews and mini-reviews on selected topics. It is the overall goal of the journal to disseminate novel approaches to an improved understanding of major metabolic disorders. The scope encompasses all topics related to the molecular and cellular pathophysiology of metabolic diseases like obesity, type 2 diabetes and the metabolic syndrome, and their associated complications. Clinical studies are considered as an integral part of the Journal and should be related to one of the following topics: -Dysregulation of hormone receptors and signal transduction -Contribution of gene variants and gene regulatory processes -Impairment of intermediary metabolism at the cellular level -Secretion and metabolism of peptides and other factors that mediate cellular crosstalk -Therapeutic strategies for managing metabolic diseases Special issues dedicated to topics in the field will be published regularly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信